Journal of Innovations in Pharmaceutical and Biological Sciences
Read the article
Visual summary · Journal of Innovations in Pharmaceutical and Biological Sciences

Management of the fungal infections and challenges associated with it

Ashwini Gayke, Ismail Moazzam

The question

Why are fungal infections a growing challenge, and what stands in the way of treating them?

  • Fungal infections are growing more common, at a rate the authors call alarming.
  • The authors link this growth directly to there being more people whose immune systems are impaired.

What was done

Millionsof people worldwide are affected by some of these fungal skin conditions
HIVone of the illnesses that impair immunity
  • The article describes superficial and subcutaneous fungal infections, which affect the skin, keratinous tissues and mucous membranes.
  • It looks at the available antifungal drugs, with which several superficial and systemic diseases are treated.
  • It sets out how fungal resistance arises and why new treatments are needed.

Key findings

Finding 1 of 5
More common
fungal infections are increasing at an alarming rate

Fungal infections are growing more common, at a rate the authors call alarming; they link this directly to the rising number of people whose immune systems are impaired.

Finding 2 of 5
Impaired immunity
tied to immunosuppressive drugs and intense chemotherapy; illnesses such as HIV play a part

Changes in medical practice, including immunosuppressive medications and intense chemotherapy, lie behind the rise in impaired immunity; HIV and other immunity-impairing illnesses have played a part as well.

Finding 3 of 5
Rarely life-threatening
but superficial and subcutaneous fungal infections can cripple quality of life

Superficial and subcutaneous fungal infections are rarely life-threatening, but they can have crippling effects on quality of life and, in some cases, can become invasive or pass to other people.

Finding 4 of 5
Resistance
of fungi to most antifungal medicines makes their therapy harder

Fungi resist most antifungal medicines - the evidence for this is well established - which complicates antifungal therapy and makes it hard to control disease. The resistance arises from physiological and genetic alterations and from selection when antifungal drugs are present.

Finding 5 of 5
New therapeutics
and other approaches against mycoses are needed, the authors say

The authors give three main reasons why novel therapeutics and other approaches are needed: antifungal drugs do not come in a wide range, resistance builds up, and biofilms confer resistance.

Why it matters

  • The authors hold that novel therapeutics and other approaches are needed to improve treatment outcomes against mycoses.
  • Because fungi resist most antifungal medicines, controlling disease is challenging.
  • Fungal pathogens use several tactics to weaken the host’s immune system and escalate infections.

How to cite

Ashwini Gayke, Ismail Moazzam. Management of the fungal infections and challenges associated with it. Journal of Innovations in Pharmaceutical and Biological Sciences. 2023;10(04):14-22. https://doi.org/10.56511/jipbs.2023.10402

Open the article